What Aphria’s Move From the NYSE to the NASDAQ Means for Stock Investors

In an unexpected move on Tuesday, one of Canada’s largest marijuana firms Aphria (TSX:APHA)(NYSE:APHA) announced that it is moving its U.S. stock listing from the New York Stock Exchange (NYSE) to the Nasdaq Global Select Market effective on Monday, June 8. Aphria’s stock listing migration will take place soon after the firm closes its fiscal year 2020 financial books on…

Read More

Is Aphria (TSX:APHA) the Best Canadian Cannabis Stock?

Investors looking for the most secure cannabis investments for long-term upside have a few strong picks right now. Perhaps one of the strongest is Aphria (TSX:APHA)(NYSE:APHA). This name sports an appealing mix of qualities from a reassuring cash runway, upward momentum, and a strong recent performance. From its last quarterly report to its outlook, here’s what cannabis investors need to…

Read More

Aurora Cannabis (TSX:ACB): 5 Transformative Moves in May

Aurora Cannabis’s (TSX:ACB)(NYSE:ACB) management is frantically rushing against time to restructure the Canadian marijuana firm’s business so as to achieve a positive operating earnings target by the third calendar quarter of 2020. The company has so far announced five disposal and acquisition transactions in May. Will the latest strategic moves help management hit near-term profitability targets? Aurora Cannabis stock price…

Read More

Could Aurora Cannabis Stock Give Up Recent Price Gains Soon?

Most investors who bought Aurora Cannabis (TSX:ACB)(NYSE:ACB) common shares during the past year are still in the red, even after the recent 117% rally in Aurora Cannabis stock price over the past few trading sessions. The marijuana firm’s latest quarterly results have shown desired progress. Can we expect the positive momentum to hold for much longer, or the company is…

Read More

Will Altria Buy Out Cronos (TSX:CRON) Stock?

Altria Group (NYSE:MO) is a giant company. Now valued at $70 billion, the tobacco behemoth has advantages that smaller competitors simply don’t possess. In today’s environment, Altria’s access to capital is most prized of all. There’s a chance the company could use its power to completely acquire its cannabis partner, Cronos Group Inc (TSX:CRON)(NASDAQ:CRON). In December of 2018, Altria and Cronos…

Read More

The Constellation Investment Is Proving to Be Canopy’s (TSX:WEED) Most Significant Competitive Advantage

You may have seen the recent news about Constellation (NYSE:STZ) exercising warrants to acquire additional shares in Canopy (TSX:WEED)(NYSE:CGC). This announcement was easy to overlook, partly because of its timing (the announcement came out after markets closed on a Friday), partly because Constellation is already Canopy’s largest shareholder, and mostly because of everything else happening in the world right now.…

Read More

The #1 Pot Stock to Buy During the Market Rally

The market rally picked up steam in recent weeks, yet many pot stocks remain depressed — and for good reason. If you want to go bargain shopping for marijuana stocks, you need to be careful. Today, some pot stocks are priced at ridiculous valuations. Fortunes are ready to be made. Other pot stocks, however, face a difficult future — one…

Read More

Canopy Growth (TSX:WEED) Stock: Is the End Near?

If there’s one industry that has been incredibly frustrating for investors of late, it’s the cannabis industry. Canopy Growth (TSX:WEED)(NYSE:CGC) in particular used to be the darling of the industry, but that has all changed. WEED stock plummeted from all-time highs back in October 2018 after legalization. Since then, WEED stock has struggled to get anywhere near those highs again. Then, the…

Read More

Aphria (TSX:APHA): 4 Takeaways From Latest Q3 2020 Earnings

Marijuana firm Aphria’s (TSX:APHA)(NYSE:APHA) stock price surged in early trading on Wednesday. The cause was the release of its latest earnings results for its fiscal third-quarter 2020, which ended in February. Aphria was one of the most closely watched cannabis stocks in April for its potential to deliver strong financial results, and it did just that. Quarterly revenue at $144.4…

Read More

Aurora Cannabis (TSX:ACB) Stock: More Pain Ahead

Speculative: it is a word that I have used to describe the cannabis sector since it first started making waves a few years ago. This week, Aurora Cannabis (TSX:ACB)(NYSE:ACB) announced a reverse stock split. This is yet another sign that the industry is struggling to gain a footing.  Pot stocks took the world by storm in late 2017, when it…

Read More